R

Red Tree Venture Capital

7 employees

Red Tree Venture Capital operates as a venture capital firm that focuses on entrepreneurs developing first-in-class.

Investor insights

Sectors invested in

Biotechnology8
Health Care6
Therapeutics4
Medical4
Life Science3
Health Diagnostics2
Biopharma2
Immunotherapy1
Seizures1
Electroencephalography (EEG)1
Point-of-care1
Epilepsy1
Healthcare1
Technology1
Brain waves1
neurodiagnostics1
disruptive1
Coma1
mental health and brain health1
Rapid EEG1

Funding rounds participated in

$1.5M sweet spot round size

Most of their 9 investments are in rounds between $25M and $108M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Therapeutics
Venture Capital
Life Science

Date founded

2020

Investments made

B

Bicara Therapeutics raised $108M on March 6, 2023

Investors: Omega Funds, Bioqube Ventures, RA Capital Management, L.P., The Invus Group, Premji Invest, F-Prime Capital Partners and Red Tree Venture Capital

C

CARGO Therapeutics raised $200M on March 1, 2023

Investors: Nextech Invest, Perceptive Advisors, RTW Investments, LP, T. Rowe Price, Samsara BioCapital, Wellington Management, Third Rock Ventures and Red Tree Venture Capital

T

Tachyon Therapeutics raised $12M on March 1, 2023

Investors: Khosla Ventures and Red Tree Venture Capital

A

Alladapt Immunotherapeutics, Inc. raised $119M on June 22, 2022

Investors: Patient Square Capital, Gurnet Point Capital, WestRiver Group and Red Tree Venture Capital

R

Rondo Therapeutics raised $67M on March 2, 2022

Investors: Novo Holdings, SV Life Sciences and Red Tree Venture Capital

C

CARGO Therapeutics raised undisclosed on January 1, 2022

Investors: Emerson Collective and Red Tree Venture Capital

M

Magnus Medical raised $25M on October 28, 2021

Investors: JAZZ Venture Partners and Red Tree Venture Capital

C

Ceribell, Inc raised $103M on April 29, 2021

Investors: RA Capital Management, L.P., Redmile Group, Longitude Capital and Red Tree Venture Capital

P

Pipeline Therapeutics raised $80M on February 11, 2021

Investors: Sectoral Asset Management, Suvretta Capital Management LLC, Hadean Ventures, Samsara BioCapital, Helicase Venture, RBV Capital, Versant Ventures, Perceptive Advisors and Red Tree Venture Capital

FAQ